Labeling of Cannabidiol Products: A Public Health Perspective
USA
Mar 30, 2020
Interest in the therapeutic use of cannabidiol (CBD) has reached a fever-pitch in recent months, as CBD-containing products appear everywhere from online retailers to grocery stores and gas stations. The widespread availability of hemp-derived CBD products is confounding given that CBD is a U.S. Food and Drug Administration (FDA)-approved drug, and thus precluded from being added to food and beverages, or included in dietary supplements. The use by manufacturers of disease-related claims on marketing materials and product labels, along with the federal legalization of hemp in December 2018, has created political pressure on FDA to promulgate regulations.
Accurate and informative labeling of hemp and hemp-derived CBD products is an important public health issue. FDA-regulated product labels are considered an essential tool for protecting consumers and enabling informed decision-making. Untruthful or unsubstantiated health-related claims, and unallowed Drug Claims, in marketing materials and on labels of CBD products may create harm by enticing consumers to forgo more evidence-based medical interventions. Furthermore, missing or inaccurate labeling of the amount of CBD, delta-9 tetrahydrocannabinol (THC), and potentially harmful contaminants such as pesticides, naturally-occurring yeast and mold or heavy metals may result in harm and/or lack of efficacy. Manufacturers of these products may reasonably be expected to understand and adhere to FDA regulations for labeling and marketing of food, dietary supplements and drugs, both over-the-counter (OTC) and prescription, even though FDA has interpreted federal law as excluding them from these categories. As manufacturers prepare for forthcoming regulations, a better understanding of the basic framework for FDA labeling and marketing regulations for food, dietary supplements and drugs is warranted.
Phosphatidylserine (soy) authorized for use as a supplementary ingredient in foodstuffs
Canada
Apr 18, 2024
New front labeling with traffic light model
Kuwait
Apr 17, 2024
MEIC deems unconstitutional the draft law on front nutrition labeling
Costa Rica
Apr 17, 2024
Nigeria/USA - Navigating regulatory challenges and safety considerations in lactation supplement development: A Nigeria and US Comparison
Nigeria
Apr 17, 2024
FDA proposed to revise the standards for registration criteria and procedures for Health Supplements
Indonesia
Apr 17, 2024
EU - Healthier Food Choices: From Consumer Information to Consumer Empowerment in EU Law
European Union
Apr 17, 2024
UK - Point-of-choice kilocalorie labelling practices in large, out-of-home food businesses: a preobservational versus post observational study of labelling practices following implementation of The Calorie Labelling (Out of Home Sector) (England) Regulations 2021
UK
Apr 15, 2024
Step-by-step labeling of sturgeon and salmon caviar has started
Russia
Apr 15, 2024
CRN new guidelines for melatonin supplements and labeling of gummy supplements
USA
Apr 15, 2024
Guidelines on soy-derived phosphatidylserine food ingredients
Israel
Apr 15, 2024
EU - Checkmating the Nutri-Score: Will Food Patriotism Prevent the Harmonization of Front-of-Pack Labeling Schemes within the EU?.
European Union
Apr 12, 2024
Argentina - Act 27642 and food labelling: a step forward in ensuring the right to proper nutrition
Argentina
Apr 12, 2024
Minnesota Democrats opposes to labeling foods containing insects
USA
Apr 12, 2024
COFEPRIS backs Supreme Court ruling on front-end warning labeling
Mexico
Apr 12, 2024
Regulatory proposals on labeling of meat products, wine and origin indication
Switzerland
Apr 12, 2024
